Greenwich LifeSciences says EMA cleared commercial GP2 lot for FLAMINGO-01 in Europe

The company said the same commercially manufactured GP2 lot already approved for U.S. use will supply about 170-180 trial sites across the U.S. and Europe, while UK and Canada reviews are being pursued separately.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.